How is ovarian cancer treated?
In one of our latest medical articles, esteemed consultant medical oncologist, Dr Rowan Miller, provides us with an...View more
Dr Rowan MillerConsultant Medical Oncologist in Central London
Professional statement
Dr Rowan Miller is a highly regarded consultant medical oncologist specialising in gynae-oncology and early phase clinical trials at University College London (UCL) and St Bartholomew’s Hospitals. Her expertise lies in the management of gynecological cancers and advancing cancer research through innovative trials, and she specialises in gynaecological cancer including ovarian/fallopian tube and endometrial cancers, and treatments including chemotherapy, targeted therapy, PARP inhibitors, and immunotherapy.
Dr Miller successfully completed her undergraduate training at the University of Oxford, obtaining an MA in physiology in 2000. She would then go on to undertake clinical training at Guy’s and St Thomas’ Hospitals in London before achieving an MBBS at the University of London in 2004. Notably, Dr Miller was awarded a Cancer Research UK Fellowship and obtained her PhD from the Institute of Cancer Research. She also impressively completed a fellowship at the Dana Farber Cancer Institute, Harvard University.
What makes Dr Miller stand out is that she focuses on novel therapies for gynaecological cancer, utilising genomics and biomarkers to guide therapy, particularly in early-phase clinical trials. Dr Miller is actively engaged in several clinical trials and leads the ESMO Translational Research and Precision Medicine Working Group, playing a key role in their consensus recommendation paper on HRD testing in ovarian cancer.
Dr Miller successfully completed her undergraduate training at the University of Oxford, obtaining an MA in physiology in 2000. She would then go on to undertake clinical training at Guy’s and St Thomas’ Hospitals in London before achieving an MBBS at the University of London in 2004. Notably, Dr Miller was awarded a Cancer Research UK Fellowship and obtained her PhD from the Institute of Cancer Research. She also impressively completed a fellowship at the Dana Farber Cancer Institute, Harvard University.
What makes Dr Miller stand out is that she focuses on novel therapies for gynaecological cancer, utilising genomics and biomarkers to guide therapy, particularly in early-phase clinical trials. Dr Miller is actively engaged in several clinical trials and leads the ESMO Translational Research and Precision Medicine Working Group, playing a key role in their consensus recommendation paper on HRD testing in ovarian cancer.
Clinics
The London Clinic
Central London, 20 Devonshire Pl, London, W1G 6BWMedical insurances accepted
Credentials
Professional experience
- 26 years of experience
- Consultant Medical Oncologist, The London Clinic (present)
Subspecialties
- Ovarian cancer
- Fallopian tube cancer
Education
- MA, Physiology, University of Oxford (2000)
- MBBS, University of London (2004)
Positions in organisations
- Lead, ESMO Translational Research and Precision Medicine Working Group (present)
Publications and conferences
- You can see Dr Miller's publications on ResearchGate.
Languages spoken
- English
Registration number: 6103994
Articles
Videos
Updates in ovarian cancer research, with Dr Rowan Miller
As part of our Staying Connected programme of online events, Ovacome were joined Dr Rowan Miller, Consultant Medica...View more
What is HRD (Homologous Recombination Deficiency) and how does it impact ovarian cancer?
In this webinar, the Ovacome team are joined by Dr Rowan Miller, Consultant Medical Oncologist specialising in gyna...View more